Viral infection triggers activation of the transcription factors NF-kB and IRF3, which collaborate to induce the expression of type I interferons (IFNs) and elicit innate antiviral response. In this report, we identified Krü ppel-like factor 4 (KLF4) as a negative regulator of virus-triggered signaling. Overexpression of KLF4 inhibited virus-induced activation of ISRE and IFN-b promoter in various types of cells, while knockdown of KLF4 potentiated viral infection-triggered induction of IFNB1 and downstream genes and attenuated viral replication. In addition, KLF4 was found to be localized in the cytosol and nucleus, and viral infection promoted the translocation of KLF4 from cytosol to nucleus. Upon virus infection, KLF4 was bound to the promoter of IFNB gene and inhibited the recruitment of IRF3 to the IFNB promoter. Our study thus suggests that KLF4 negatively regulates cellular antiviral response.
INTRODUCTION
Germline-encoded pattern-recognition receptors (PRRs) detect the nucleic acid from invading viruses and initiate a series of cellular events that induce expression of type I interferons (IFNs). 1 Type I IFNs further induce transcriptional induction of a wide range of downstream antiviral genes, the products of which lead to inhibition of viral replication, apoptosis of virusinfected cells and cellular antiviral response.
1,2 Therefore, type I IFNs play a central role in innate antiviral immunity. It has been well documented that transcriptional induction of type I IFN genes requires the coordinated activation of multiple transcription factors and their subsequent assembly onto the enhancers of type I IFN genes. For example, the IFNB1 gene promoter contains conserved enhancer elements recognized by NF-kB (kB site) and IRF3 (ISRE site, also known as PRDIII or IRFE). 1, 3 So far, at least two families of PRRs for recognition of viral RNAs have been well characterized. 4 One is membrane-bound Toll-like receptors (TLRs) such as TLR3 and TLR7/8. Engagement of TLR3 by double-stranded RNA triggers TRIFmediated signaling pathways, while TLR7/8 recognizes ssRNA to activate MyD88-dependent signaling. 5, 6 The other involves the cytosolic RIG-I-like receptors including RIG-I and MDA5. 7 The binding of the C-terminal RNA helicase domain of RIG-I to viral RNA results in its conformational change to form a prion-like structure of the N-terminal CARD domains, which recruits the mitochondrial adaptor VISA (also called MAVS, IPS-1, Cardif) and promote the CARD domain of VISA to form prion-like particles which trigger downstream signaling cascades. [8] [9] [10] [11] [12] [13] A number of proteins have been implicated in mediating TRIF-, MyD88-or VISA-dependent signaling pathways, including TRAFs, MITA, IKKs, TRADD and RIP1. [14] [15] [16] [17] [18] Among these components, TRAF2 and TRAF6 facilitate K63-linked polyubiquitination of RIP and NEMO/IKKc, respectively, which causes the activation of NF-kB. MITA and GSK3b are responsible for the recruitment and phosphorylation of TBK1, respectively, which leads to the phosphorylation and activation of IRF3 or IRF7. 19, 20 These transcription factors enter nucleus to promote the transcription of type I IFN genes. However, uncontrolled induction of type I IFNs could cause severe side effects such as cytokine storm and even death. Host thus has developed various strategies to negatively regulate virus-triggered induction of type I IFNs by targeting distinct signaling components. For example, we have demonstrated that the E3 ubiquitin ligase RNF5 negatively regulates virus-triggered signaling by targeting MITA for ubiquitination and degradation, and the deubiquitinases OTUB1/2 inhibit TRAF3/6-mediated anti-viral signaling. [21] [22] [23] Whether and how other molecules are involved in regulating virus-triggered type I IFN induction is of great interest. Krüppel-like factors (KLFs) belong to a family of transcriptional regulators consisting of seventeen members that contain highly conserved C-terminal DNA binding domains, which has been implicated in cell proliferation, differentiation and growth. The highly conserved C-terminal DNA binding domains consist of three C2H2 zinc fingers that bind to 'GCbox' or 'CACCC-box' motifs in the promoters and/or mediate protein-protein interactions. The N-terminal domains of KLFs contain much more variable activation or repression regions that allow KLFs to participate in different physiological processes. 24 In our previous study, we have identified KLF6 as a co-activator of NF-kB that is essential for NF-kB-mediated transcription of selected downstream genes after TNF-a-and IL-1b stimulation. 25 Whether and how other KLFs function in virus-triggered signaling is currently unknown.
In this study, we found that another KLF family member, KLF4, inhibited virus-triggered signaling. Overexpression of KLF4 inhibited virus-induced activation of IFN-b promoter in a dose-dependent manner. In contrast, knockdown of KLF4 potentiated virus-triggered transcription of IFNB1 and downstream genes. In addition, KLF4 inhibited cellular antiviral response. Viral infection resulted in the translocation of KLF4 from cytosol to nucleus and KLF4 binding to IFNB promoter. Our findings thus demonstrate that KLF4 negatively regulates virus-triggered signaling.
MATERIALS AND METHODS

Reagents and antibodies
Recombinant TNF-a (Peprotech: Rocky Hill, NJ, USA), recombinant IL-1b (Peprotech), mouse monoclonal antibodies against FLAG (Sigma: St, Louis, MO, USA), HA (Convance: Princeton, NJ, USA), b-tublin (Sigma), IRF3 (Santa Cruz Biotechnology: Santa Cruz, CA, USA), GFP (Santa Cruz Biotechnology), p65 (CST: Boston, MA, USA), p-P65(S536) (CST) and p-IkBa(S32/36) (CST) were purchased from the indicated manufacturers. SeV, GFP-vesicular stomatitis virus (VSV) were previously described. 15, 26, 27 Ectromelia virus (ECTV) is provided by Professor Hanzhong Wang in Wuhan Institute of Virology. Mouse anti-KLF4 was raised against recombinant human full-length KLF4.
Constructs NF-kB, ISRE, the IFN-b promoter and IRF1 luciferase reporter plasmids, mammalian expression plasmids for HA-or Flagtagged RIG-I, MDA5, VISA, MITA, TBK1, IKKe, IRF3 and IRF7 were previously described. 9, 26, 28 Mammalian expression plasmids for human HA-, Flag-KLF4 and its mutants were constructed by standard molecular biology techniques.
Transfection and reporter assays. The experiments were performed as previously described 29 Briefly, HEK293 cells (1310 5 ) were seeded on 24-well plates. One day later, the cells were transfected by calcium phosphate precipitation method. In each transfection, 0.01 mg of pRL-TK (Renilla luciferase) reporter plasmid was added as internal control. Eighteen hrs after transfection, luciferase assays were performed using a dual-specific luciferase assay kit (Promega: Madison, WI, USA). For RNAi experiments, luciferase assays were performed at least 24 h after transfection.
Immunoblot analysis HEK293 cells were seeded on six-well plates or 10 cm dishes and transfected on the following day by calcium phosphate precipitation or lipofectin. Cells were selected by antibiotics and infected with virus for different time points. The cells were lysed in lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton, 1 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). Cell lysates were analyzed by standard immunoblot procedures.
Virus manipulation
Viral infection was performed when cells were 70% confluent. The culture medium was replaced by serum-free DMEM before GFP-VSV was added at various multiplicities of infection for 1 h. The cells were washed twice by PBS and fed with DMEM containing 2% FBS. GFP-VSV replication in HEK293 cells was visualized by fluorescence microscopy, and cells were harvested for flow cytometry and immunoblot analysis.
RNAi experiments
Double-strand oligonucleotides corresponding to the target sequences were cloned into the pSuper.Retro RNAi plasmid (Oligoengine Inc.: Seattle, WA, USA). The following sequences were targeted for human KLF4 cDNA: #1: CAGAATTGGACCCGGTGTA #2: GGTCATCAGCGTCAGCAAA #3: GGCAAAACCTACACAAAGA
Real-time PCR
Total RNA was isolated from cells and subjected to real-time PCR analysis to measure expression of mRNA. Gene-specific primer sequences were as follows:
Subcellular fractionation HEK293 cells ( 2310 7 ) infected with SeV or left uninfected for various time points were washed with PBS by three times. Subcellular fractionations were separated by Nucl-Cyto preparation kit (Applygen: Beijing, China). In brief, cells were lysed by douncing 25 times in 1 ml CER. The homogenates were centrifuged twice at 500g for 5 min to precipitate cytosol. The pellets were washed with NER and centrifuged twice at 4000g for 5 min to precipitate nucleus. The nucleus fraction was lysed in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, and 1% Nonidet P-40, protease inhibitor mixture) for immunoblotting analysis.
Chromatin immunoprecipitation (ChIP) assays
Immunoprecipitation was performed with 2 mg of IRF3 antibody, 2 mg of Flag antibody, 5 mg of KLF4 antibody or control antibody, and the immune complexes were absorbed with protein A beads or protein G beads blocked with bovine serum albumin and salmon sperm DNA (Millipore: Bedford, MA, USA). Gene-specific primer sequences were as following: IFNB:
59-CTGAAAGGGAGAAGTGAAAGTGG-39 (forward), 59-TCGAAAGGTTGCAGTTAGAATGTC-39 (reverse).
Statistical analysis
Students t-test were performed this study. P values of less than 0.05 were considered statistically significant.
RESULTS
Overexpression of KLF4 inhibits virus-induced signaling
Previously, we have screened KLFs that potentially regulate TNF-a-or IL-1b-triggered signaling and identified KLF6 as a co-activator of NF-kB in mediating TNF and IL-1 signaling. 25 Interestingly, we also noted that KLF4 substantially inhibited TNF-a-and IL-1b-induced activation of NF-kB. In addition, we found that KLF4 inhibited SeV-induced activation of NFkB ( Figure 1a ). KLF4 is a tumor suppressor and is ubiquitously expressed in mammalian tissues. It is unclear whether KLF4 functions in cellular antiviral response. We thus made Flag-or HA-tagged expression plasmid encoding human KLF4 and examined its role in virus-triggered signaling.
As shown in Figure 1b (Figure 1g ). These results suggest that KLF4 inhibits virus-triggered signaling.
Knockdown of KLF4 potentiates virus-induced expression of IFNB1
To determine the roles of endogenous KLF4, we made three RNAi constructs (pSuper-KLF4-RNAi #1-3) containing different sequences targeting the human KLF4 mRNA. Immunoblot analysis indicated that these vectors could inhibit the expression of endogenous KLF4 (Figure 2a) . Results from reporter assays showed that these three KLF4-RNAi vectors markedly enhanced SeV-, cytoplasmic poly(I:C)-or poly(dA:dT)-induced activation of the IFN-b promoter in HEK293 cells (Figure 2b and c) . In addition, we found that knockdown of KLF4 potentiated ECTV-or HSV-1-induced activation of IFNb promoter in HeLa cells (Figure 2d and e), indicating that KLF4 negatively regulates RNA or DNA virus-triggered activation of IFN-b promoter in multiple types of cells. We further found that knockdown of KLF4 potentiated SeV-triggered activation of ISRE and NF-kB, and IL-1b-or TNFa-induced activation of NF-kB in HEK293 cells in reporter assays (Figure 2f and g ). In the similar experiments, knockdown of KLF4 had no effects on IFN-c-triggered activation of IRF-1 promoter (Figure 2h ). Consistent with these observations, results from real-time PCR experiments confirmed that knockdown of KLF4 potentiated SeV-induced transcription of IFNB1, RANTES and ISG15 (Figure 2c ). Taken together, these results suggest that KLF4 is a negative regulator of SeV-triggered signaling.
Because KLF4 inhibited virus-triggered signaling, we examined its role in cellular antiviral response. We found that the replication of GFP-tagged VSV was inhibited in KLF4-knockdown cells compared with control cells as monitored by GFP expression (Figure 3) . These results indicate that KLF4 negatively regulates cellular antiviral response.
KLF4 regulates virus-triggered signaling at the level or downstream of IRF3
Various molecules have been reported to mediate SeV-triggered signaling, including RIG-I, MDA5, TRIF, VISA TBK1, IKKe, IRF3 and IRF7. To determine the molecular level at which KLF4 regulated virus-induced signaling, we performed reporter assays. As show in Figure 4a , overexpression of KLF4 inhibited ISRE activation induced by overexpression all of the above-mentioned molecules. On the contrary, KLF4-RNAi potentiated IRF3-mediated activation of ISRE (Figure 4b ). However, in our transient transfection and coimmunoprecipitation assays, we did not observe the interactions between KLF4 and those signaling components (data not shown). These data suggest that KLF4 functions at the level or downstream of IRF3/ 7 to inhibit virus-triggered signaling.
KLF4 binds to the promoter of IFNB To determine the mechanisms by which KLF4 regulated virustriggered type I IFN signaling, we examined the effects of KLF4-RNAi on virus-triggered phosphorylation of p65 and IkBa as well as the nuclear translocation of IRF3 or p65 that are hallmarks of activation of NF-kB and IRF3. However, knockdown of KLF4 neither affected the phosphorylation of p65 or IkBa nor potentiated the nuclear translocation of p65 or IRF3, indicating that KLF4 is not involved in the upstream signaling events after viral infection (Figure 5a) .
It has been reported that the C-terminal domain of KLF4 contains DNA binding activity, while the N-terminal domain of KLF4 recruits cofactors for transcriptional repression or activation of target genes. In reporter assays, we found that both the N-terminal and C-terminal domains were required for optimal inhibition of virus-triggered activation of IFN-b promoter, indicating that the intact structure of KLF4 is important for its function (Figure 5b ). In addition, we observed that KLF4 was located in the cytosol and nucleus, while SeV infection resulted in nuclear accumulation of KLF4 (Figure 5a and c), indicating that KLF4 may exerts the inhibitory function in the nucleus. Interestingly, we found that KLF4 was bound to the promoter of IFNB gene and this binding was promoted by SeV infection (Figure 5e ). In addition, the binding of IRF3 to the promoter of IFNB gene was inhibited by overexpression of KLF4 (Figure 5d ). These data suggest that KLF4 is a negative regulator of cellular antiviral response and functions on the promoter of IFNB.
DISCUSSION
The innate immune system is the first line of host defense against viral infection. After detection of invading viruses, host cells initiate a series of signaling events that lead to the expression of type I IFNs which play a crucial role in innate antiviral immunity. A set of molecules have been characterized as mediators for RNA virus-triggered signaling, including RIG-I, MDA5, VISA, MITA and TRAFs. However, uncontrolled induction of type I IFNs is harmful to the host. In the present study, we identified the transcription factor KLF4 as a negative regulator of innate cellular antiviral response.
In our study, we found that overexpression of KLF4 inhibited SeV-triggered activation of ISRE and IFN-b promoter in a dose-dependent manner, whereas knockdown of KLF4 potentiated virus-triggered induction of downstream genes including IFNB1, RANTES and ISG 15 and inhibited replication of VSV. These results together demonstrate that KLF4 plays an inhibitory role in virus-triggered type I IFN signaling.
It has been demonstrated that KLF4 is a transcription factor that controls proliferation, differentiation, and apoptosis. KLF4 modulates the JAK-STAT3 pathway in cortical neural progenitors. 24, 30 In our study, we found that KLF4 was located in both the cytosol and the nucleus. SeV infection resulted in the translocation of KLF4 from cytosol to nucleus. Overexpression of KLF4 inhibited virus-induced activation of ISRE and NF-kB, while knockdown of KLF4 had opposite effects. However, knockdown of KLF4 had no effect on virus-triggered phosphorylation of p65, IkBa or the nuclear translocation of IRF3 and p65. These data together indicate that KLF4 inhibits virus-triggered type I IFN signaling in the nucleus and functions at the level or downstream of IRF3. The C-terminal and N-terminal domains are responsible for the DNA binding and the recruitment of cofactors, respectively. Unexpectedly, neither the C-terminal nor the N-terminal domain alone inhibited SeV-induced activation of IFN-b promoter, indicating that the intact structure of KLF4 is necessary for its inhibitory function. We did not detect the interactions between KLF4 and RIG-I, MDA5, VISA, MITA, TRAFs, IRF3 or p65. Results from ChIP analysis indicated that KLF4 was bound to the promoter of IFNB gene and thus inhibited the binding of IRF3 to the IFNB promoter after viral infection. These data together suggest that KLF4 inhibits viral infectiontriggered expression of IFNB by competitively binding to the IFNB promoter with IRF3. Further investigations need to be focused on characterizing the sequence target(s) of KLF4. Nonetheless, our study has demonstrated that KLF4 plays a previously uncharacterized role in virus-triggered signaling.
